The approval was based on data from 2 randomized, double-blind, placebo-controlled trials, ARCADIA 1 and ARCADIA 2.

In children with mild-to-moderate AD, the use of intermittent ... but not as efficacious as a mid-potency topical steroid (Beck, 2005). Studies comparing tacrolimus and pimecrolimus demonstrated ...

It is also more common in adult women who use moderate to high potency topical corticosteroids on the face and genital area.' ...

The US FDA has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

In this article the use of wet wraps for short-term outpatient treatment of moderate-to-severe ... A low or medium potency topical corticosteroid should be applied to all of the areas affected ...